Search
Search Results
-
Investigation of the pathogen-specific antibody response in periprosthetic joint infection
PurposePeriprosthetic joint infections (PJIs) are a very demanding complication of arthroplasty. Diagnosis of PJI and pathogen identification pose...
-
Robust antibody response after the third mRNA coronavirus vaccination in Japanese hemodialysis patients
BackgroundHemodialysis patients have chronic kidney disease, are often elderly, and have many complications such as hypertension, type 2 diabetes,...
-
Predictors of a weak antibody response to COVID-19 mRNA vaccine in systemic lupus erythematosus
ObjectivesTo characterize the antibody response to COVID-19 mRNA vaccination in patients with Systemic Lupus Erythematosus (SLE) and identify...
-
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients
SARS-CoV-2 and its variants cause CoronaVIrus Disease 19 (COVID-19), a pandemic disease. Hematological malignancies increase susceptibility to severe...
-
A stronger antibody response in increased disease severity of SARS-CoV-2
BackgroundAn assessment of the factors that interfere with serum levels and the persistence of anti-SARs-CoV-2 IgG antibodies is essential in order...
-
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts
To determine the efficacy of SARS-CoV-2 mRNA vaccination for allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, we measured...
-
Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: The GeroCovid Vax Study
Background and ObjectivePolypharmacy is common in older adults, particularly among those living in long-term care facilities. This condition...
-
Intratumoral delivery of a Tim-3 antibody-encoding oncolytic adenovirus engages an effective antitumor immune response in liver cancer
Background and PurposeThe use of oncolytic viruses as a gene therapy vector is an area of active biomedical research, particularly in the context of...
-
Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study
BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has dramatically impacted global health, and patients with type 2 diabetes have been...
-
Antibody response to COVID-19 vaccination in patients with lymphoma
Patients with lymphoma are at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therefore, evaluation of SARS-CoV-2...
-
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
We evaluated anti-spike protein antibody (anti-S) production in 130 hematopoietic stem cell transplant (HSCT) recipients who received the coronavirus...
-
Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria
BackgroundRTS,S/AS01 has been recommended by WHO for widespread implementation in medium to high malaria transmission settings. Previous analyses...
-
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
BackgroundHeterogeneity of the population in relation to infection, COVID-19 vaccination, and host characteristics is likely reflected in the...
-
Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
AimObesity is a disease complicating the course of COVID-19 and SARS-CoV-2 vaccine effectiveness in adults with obesity may be compromised. Our aim...
-
Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study
IntroductionPatients with cirrhosis have a higher risk of severe COVID-19 and mortality and are high-priority patients for vaccination. However,...
-
Antibody response, associated symptoms and profile of patients presumably infected by SARS-CoV-2 with taste or smell disorders in the SAPRIS multicohort study
BackgroundTaste or smell disorders have been reported as strongly associated with COVID-19 diagnosis. We aimed to identify subject characteristics,...
-
Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
BackgroundCOVID-19 vaccination is highly recommended to multiple sclerosis (MS) patients. Little is known about the role of patients’ clinical and...
-
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization
COVID-19 inactivated vaccine-induced humoral responses in patients with lung cancer (LCs) to SARS-CoV-2 wild-type (WT) strain and variants BA.4/5...
-
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
COVID-19 in patients with hematological diseases is associated with a high mortality. Moreover, preventive vaccination demonstrated reduced efficacy...
-
Alternating 3 different influenza vaccines for swine in Europe for a broader antibody response and protection
Heterologous prime-boost vaccination with experimental or commercial influenza vaccines has been successful in various animal species. In this study,...
